Projects funded by the NCN

Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

Call: OPUS 29 , Panel: NZ7

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

Call: OPUS 28 , Panel: ST4

Principal investigator: prof. Ewelina Wioletta Lipiec

Uniwersytet Jagielloński

Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra...

Call: OPUS 28 (LAP) , Panel: NZ5

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

Call: OPUS 28 , Panel: ST5

Principal investigator: dr hab. Michał Piotr Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu

Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while ...

Call: OPUS 26 , Panel: NZ5

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Call: OPUS 25 , Panel: NZ7

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

Call: PRELUDIUM BIS 4 , Panel: NZ7

Principal investigator: prof. Tomasz Adam Gośliński

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

Call: OPUS 23 , Panel: NZ5

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych PAN

Reversible senescence as a new mechanism of cancer cell resistance for chemotherapy. Analysis of the mechanism of cancer...

Call: SONATINA 5 , Panel: NZ3

Principal investigator: dr Karolina Anna Staniak

Politechnika Warszawska, Wydział Chemiczny

Increasing the precision of chimeric antigen receptor (CAR)-mediated anticancer immunotherapy by using the chemokine-ind...

Call: OPUS 19 , Panel: NZ6

Principal investigator: dr hab. Radosław Zagożdżon

Warszawski Uniwersytet Medyczny

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

Call: OPUS 19 , Panel: NZ7

Principal investigator: prof. Tomasz Adam Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherap...

Call: PRELUDIUM 19 , Panel: NZ5

Principal investigator: Małgorzata Kubczak

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Foldback triplex-forming oligonucleotides as novel tools for G-quadruplex unfolding and selective inhibition of c-Myc on...

Call: OPUS 19 , Panel: NZ7

Principal investigator: prof. Anna Pasternak

Instytut Chemii Bioorganicznej PAN

Novel bispecific G-quadruplex conjugates as potential anticancer agents

Call: PRELUDIUM 18 , Panel: NZ7

Principal investigator: dr Carolina Sofia Pereira Roxo

Instytut Chemii Bioorganicznej PAN

Dual-targeted biodegradable polymeric micelles for anticancer drug delivery

Call: SONATA BIS 9 , Panel: NZ7

Principal investigator: dr Katarzyna Jelonek

Centrum Materiałów Polimerowych i Węglowych PAN

Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Godefridus J Peters

Gdański Uniwersytet Medyczny, Wydział Lekarski

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Evaluation of tumour metabolomic response to imatinib in a study of mouse xenograft models with gastrointestinal stromal...

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: Szymon Macioszek

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

Call: OPUS 12 , Panel: NZ6

Principal investigator: dr hab. Radosław Zagożdżon

Warszawski Uniwersytet Medyczny, Wydział Lekarski

System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

Call: OPUS 11 , Panel: ST7

Principal investigator: prof. Andrzej Świerniak

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

Call: OPUS 11 , Panel: ST8

Principal investigator: prof. Stefan Jurga

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan...

Call: HARMONIA 7 , Panel: ST5

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases

Call: PRELUDIUM 9 , Panel: NZ4

Principal investigator: Natalia Iwona Kułach

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Does cyclic hypoxia specifically affect microRNA expression in human endothelial cells?

Call: PRELUDIUM 9 , Panel: NZ7

Principal investigator: dr Kinga Kochan-Jamrozy

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

The new tools for research mechanisms of anticancer activity of photosenthisisers used for photodynamic therapy of cance...

Call: OPUS 8 , Panel: NZ5

Principal investigator: dr hab. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Engineering of intelligent inhalable therapeutics with the capacity for guided accumulation and triggered release of act...

Call: HARMONIA 6 , Panel: ST5

Principal investigator: prof. Elżbieta Pamuła

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

From a molecular in silico model to cellular response in vitro. Modified nucleosides as photo and/or radiosensitizers of...

Call: MAESTRO 6 , Panel: ST4

Principal investigator: prof. Janusz Adam Rak

Uniwersytet Gdański, Wydział Chemii

Studies on the biological activity of selected aminomethylidenebisphosphonic acids

Call: OPUS 7 , Panel: NZ4

Principal investigator: dr Anna Nasulewicz-Goldeman

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Anticancer activity of the thiosemicarbazone derivatives

Call: SONATA 7 , Panel: NZ7

Principal investigator: dr Anna Dominika Mrozek-Wilczkiewicz

UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

Cellular and molecular mechanism of action of PPI dendrimer complexes with nucleoside analogue anticancer drugs

Call: OPUS 7 , Panel: NZ3

Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Combined induction of cell death of canine leukemia and lymphoma.

Call: OPUS 2 , Panel: NZ5

Principal investigator: dr hab. Andrzej Marek Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

New drug carriers in targeted anticancer therapy

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: Mateusz Psurski

Politechnika Wrocławska, Wydział Chemiczny

Iron chelators- the novel approach to anticancer therapy

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: Maciej Michał Serda

UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii